Clifford Chance has advised Royal DSM (“DSM”) and Sinochem Group on the disposal of their 50/50 joint venture DSM Sinochem Pharmaceuticals (“DSP”), the global leader in…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
